Roche targets 2 vs GSS 12; as singular tests this chops cost to Medicare down from potentially $252 plus GP visits + additional costs from failure to diagnose lack of early treatment
Abbott 4 vs GSS 12
qiagen 1 vs GSS 12
IMHO the real value long term to governments that fund reproductive assistance is the reduction in long term fertility issues by the use of screening - as opposed to stab in the dark individual testing - the superficial symptoms go away the testing stops the condition moves to PID - and LT infertility issues
- Forums
- ASX - By Stock
- GSS
- Ann: Presenting at Bell potter healthcare conference
Ann: Presenting at Bell potter healthcare conference, page-11
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GSS (ASX) to my watchlist
|
|||||
Last
73.0¢ |
Change
0.010(1.39%) |
Mkt cap ! $165.3M |
Open | High | Low | Value | Volume |
71.5¢ | 73.0¢ | 71.0¢ | $373.9K | 519.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 71.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
73.0¢ | 9999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 0.710 |
1 | 1 | 0.705 |
7 | 72684 | 0.700 |
1 | 8500 | 0.695 |
1 | 1450 | 0.690 |
Price($) | Vol. | No. |
---|---|---|
0.730 | 9999 | 1 |
0.740 | 6000 | 1 |
0.750 | 11470 | 1 |
0.760 | 14801 | 1 |
0.775 | 1291 | 1 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online